AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-24680724_ITM" title="Facts and information about Forest Labs gets FDA panel approval for Alzheimer's drug.">Forest Labs gets FDA panel approval for Alzheimer's drug.</a>
Close
Set up an RSS feed that alerts you when new articles from Asia Africa Intelligence Wire are available.
Frequently asked questions about RSS feeds
Forest Labs gets FDA panel approval for Alzheimer's drug.
(From Chemical Business NewsBase - Chemical Market Reporter)
A US FDA advisory committee has recommended that Forest Laboratories is given approval to market the Alzheimer's disease treatment Namenda (formerly known as memantine). If approved, this will be the first …
Related articles from newspapers, magazines, journals, and more
-
- Forest Laboratories and Lundbeck enter into settlement agreement with...
-
News wire article from: Asia Africa Intelligence Wire
October 6, 2005
700+ words
-
- Forest Laboratories Holdings and Almirall announce a development and...
-
News wire article from: Chemical Business Newsbase
April 10, 2006
700+ words
-
- Forest Laboratories Inc and Paion GmbH announce development and marketing...
-
News wire article from: Asia Africa Intelligence Wire
July 6, 2004
700+ words
-
- Forest Laboratories announces acquisition of Cerexa Inc.
-
News wire article from: Chemical Business Newsbase
December 14, 2006
700+ words
-
- Forest Laboratories discusses disclosure of citalopram clinical trial data in...
-
News wire article from: Asia Africa Intelligence Wire
June 24, 2004
700+ words
